Thinking to myself that if we get FDA approval to even check for 3 diseases we will still have the same amount of customers available as if we could check for 6 diseases or 12 diseases because they still need to check for the 3 relevant ones.
Each check brings in money so we will be still raking in the money as if we had the full suite of diseases. Yes/No
Ann: ResApp Presentation at TechKnow Invest Roadshow, page-34
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)